The global tinea pedis treatment market is expected to reach US$ 1.35 billion in 2022, and to grow at a CAGR of 5.2% to exceed US$ 2.24 billion by the end of 2032. In terms of disease indication, the interdigital tinea pedis treatment market is expected to command a 68.3% share in 2022.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2084
The research presented in this report is organised in a way that allows the user to easily grasp various key insights of the global market for tinea pedis treatment. The market is evaluated across the key regions of North America, Asia Pacific excluding Japan (APEJ), Japan, Latin America, Western Europe, Eastern Europe, the Middle East, and Africa, with future projections for the global tinea pedis treatment market slated for a 9-year period.
Global Tinea Pedis Treatment Market: Segmental Analysis
The global market for tinea pedis treatment is segmented by disease type, by route of administration, by distribution channel, by drug class and by region.
In terms of revenue, the antifungals segment is the largest by drug class. This segment has dominated the global market since 2012 and is expected to continue to do so in the coming years. During the assessment period, the steroids and anti-infective combinations segment is expected to grow at the fastest rate, with a CAGR of 5.5%.
Because of the increasing use of oral therapies to treat fungal infections, the oral route of administration is expected to grow at a faster rate during the forecast period. The topical segment, on the other hand, has a higher valuation and is expected to reach US$ 1,356.6 million by the end of the assessment year.
Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-question/rep-gb-2084
Drug stores are a profitable distribution channel, ranking second in terms of value and growth rate. The hospital pharmacy segment is the largest, with a valuation of approximately US$ 402 Mn in 2017 and is expected to lead the global market.
The interdigital tinea pedis segment, by disease type, offers high growth opportunities in the tinea pedis treatment market and is expected to grow at a 4.5% CAGR during the forecast period.
North America is the largest region and has a high market attractiveness index. In terms of valuation, APEJ is the second largest regional market for tinea pedis treatment and the fastest growing region, with a CAGR of 6.1% recorded during the forecast period.
Global Tinea Pedis Treatment Market: Competitive Analysis
The research report on the global tinea pedis treatment market includes a detailed analysis on the competitive scenario that covers details such as SWOT analysis, key financials, mergers and acquisitions, key innovations and developments, regional presence and product portfolio of top companies such as Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., USA, Breckenridge Pharmaceutical, Inc., NorthStar Rx LLC, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc., AvKare, Inc., Novartis AG, Sebela Pharmaceuticals Inc., Bayer AG, Blueberry Therapeutics Ltd., GlaxoSmithKline Plc., Exeltis USA, Valeant Pharmaceuticals, Inc., CorePharma, LLC, McNeil Consumer Healthcare, Aqua Pharmaceuticals LLC and Mylan N.V.
Buy Tinea Pedis Treatment Market Research Report@ https://www.futuremarketinsights.com/checkout/2084
Global Tinea Pedis Treatment Market: Factors Influencing Growth
Increased fungal infections, increased investments in emerging economies, increased awareness and research funding, increased emphasis on improving distribution channels, increased preference by podiatrists and dermatologists, increased public-private partnerships to facilitate new developments for effective tinea pedis treatment, advancements in personalised medicines, and increased government support are all driving the global tinea pedis treatment market forward. However, factors such as high drug costs, a lack of diagnostic tools for treatment, fluctuating prices, and growing alternatives for tinea pedis treatment are impeding market growth.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
